(2R,3R,4S,5R)-2-(6-(4-([1,1'-Biphenyl]-4-yl)piperazin-1-yl)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

ID: ALA4475619

PubChem CID: 155537886

Max Phase: Preclinical

Molecular Formula: C26H28N6O4

Molecular Weight: 488.55

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  OC[C@H]1O[C@@H](n2cnc3c(N4CCN(c5ccc(-c6ccccc6)cc5)CC4)ncnc32)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C26H28N6O4/c33-14-20-22(34)23(35)26(36-20)32-16-29-21-24(27-15-28-25(21)32)31-12-10-30(11-13-31)19-8-6-18(7-9-19)17-4-2-1-3-5-17/h1-9,15-16,20,22-23,26,33-35H,10-14H2/t20-,22-,23-,26-/m1/s1

Standard InChI Key:  UWJIVFICFJJKOS-HUBRGWSESA-N

Molfile:  

 
     RDKit          2D

 36 41  0  0  0  0  0  0  0  0999 V2000
   36.0834  -10.0168    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.0939   -8.6934    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.6110   -9.3515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8713   -8.9535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8581   -9.7752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5592  -10.1951    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.2780   -9.7980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2912   -8.9763    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.5856   -8.5518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5976   -7.7346    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.3182   -7.3383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3322   -6.5248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6324   -6.1020    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.9170   -6.4989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9013   -7.3186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8206  -10.7945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0406  -11.0382    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.0314  -11.8554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8057  -12.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2934  -11.4610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1105  -11.4702    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.0495  -12.8967    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.3649  -12.3282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6221  -11.9874    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.6458   -5.2863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3626   -4.8915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3780   -4.0752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6774   -3.6528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9599   -4.0526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9479   -4.8676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6926   -2.8385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4089   -2.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4232   -1.6264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7221   -1.2049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0051   -1.6057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9942   -2.4207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0
  4  2  1  0
  2  3  2  0
  3  1  1  0
  4  5  2  0
  4  9  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 15  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 16  1  0
 16  1  1  1
 20 21  1  6
 19 22  1  6
 18 23  1  1
 23 24  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 13 25  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 31  1  0
 28 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4475619

    ---

Associated Targets(Human)

NHDF (1164 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADK Tchem Adenosine kinase (1481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
adoK Adenosine kinase (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 488.55Molecular Weight (Monoisotopic): 488.2172AlogP: 1.43#Rotatable Bonds: 5
Polar Surface Area: 120.00Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.45CX Basic pKa: 3.65CX LogP: 2.23CX LogD: 2.23
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.38Np Likeness Score: -0.02

References

1. Crespo RA, Dang Q, Zhou NE, Guthrie LM, Snavely TC, Dong W, Loesch KA, Suzuki T, You L, Wang W, O'Malley T, Parish T, Olsen DB, Sacchettini JC..  (2019)  Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase.,  62  (9): [PMID:31002508] [10.1021/acs.jmedchem.9b00020]

Source